ISPOR Europe 2024
Held 17-20 November 2024 | Barcelona, Spain
View the Digital Conference Pass Recordings 4 December through 9 January
Learn More Access Digital Conference PassGenerating Evidence Toward Health and Well-Being
The ISPOR Europe 2024 conference, themed “Generating Evidence Toward Health and Well-Being,” was held 17 - 20 November in Barcelona, Spain. The conference program centered on the importance of scientific evidence in understanding and improving the health and well-being of people across the globe. Sessions focused on the science, practice, and policies of healthcare value assessment and promoted a broader view of health economics and outcomes research (HEOR) that considers the physical, mental, and social health aspects of innovation.
The conference also delved into:
- Joint Clinical Assessments
- Real-World Data
- Expanded Definition of Healthcare Value
- Patient-Centered Research
- Digital Transformation of Health
- European Regulatory and Policy Developments
ISPOR Real-World Evidence Summit 2024—17 November
A co-located event at ISPOR Europe 2024
The ISPOR Real-World Evidence Summit 2024 was held on 17 November and was a colocated event with ISPOR Europe 2024.
Speakers
Director | National Institute for Value and Technologies in Healthcare (NIH)
Senior Policy Analyst, Health Division | Organization for Economic Co-operation and Development (OECD)
Section Head, Health Data Sciences and Professor | Botnar Research Centre, University of Oxford and Erasmus MC
Associate Professor & Director | Harvard Medical School & The Institute for Technology Assessment at Massachusetts General Hospital
Head at HTA Strategy and External Engagement | National Centre for Pharmacoeconomics, Dublin, Ireland & Discipline of Pharmacology and Therapeutics, Trinity College Dublin
Advisor, Co-Chair JCA Subgroup under the HTA Coordination Group, Research, Development & International Affairs | National Health Care Institute
Head of the Real World Evidence (TDA-RWE), Data Analytics and Methods Task Force (TDA) | European Medicines Agency
Professor of Medicine and Epidemiology & Chief of the Division of Pharmacoepidemiology, Department of Medicine | Harvard Medical School & Brigham and Women’s Hospital